$2.29
0.02 (+0.88%)
Ariad Pharmaceuticals, Inc. (ARIA)
CAPS Rating:
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

RSS Headlines
Fool UK